The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Abstract
Autism is a neurodevelopmental disorder characterized by dysfunction in three core behavioral domains: repetitive behaviors, social deficits, and language abnormalities. There is evidence that abnormalities exist in peptide systems, particularly the oxytocin system, in autism spectrum patients. Furthermore, oxytocin and the closely related peptide vasopressin are known to play a role in social and repetitive behaviors. This study examined the impact of oxytocin on repetitive behaviors in 15 adults with autism or Asperger's disorder via randomized double-blind oxytocin and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviors: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant reduction in repetitive behaviors following oxytocin infusion in comparison to placebo infusion. Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Improvements in repetitive behaviors in adults with autism following oxytocin infusion have been demonstrated [169] as well as positive effects on social behaviors and cognition [170].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [169]
In the citing paper
“The neuromodulator oxytocin (OT) has been shown to improve social deficits in both ASD and other disorders accompanied by social deficits (Guastella et al., 2010, 2010; Hollander et al., 2002, 2007; Yatawara et al., 2015; Young and Barrett, 2015).”
From Oxytocin enhances gaze-following responses to videos of natural social behavior in adult male rhesus monkeys (2016) · cites this paper as Hollander et al., 2002
In the citing paper
“reduce repetitive behaviors (Hollander et al., 2003)”
From Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome (2012) · cites this paper as Hollander et al., 2003
In the citing paper
“This study demonstrated that administration of OT led to a decrease in a core ASD symptom, RRB.”
From Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders (2014) · cites this paper as Hollander et al., 2003
In the citing paper
“Overall, these observed effects on repetitive behaviors are in line with previous trials with adult men with ASD showing beneficial effects of OT on repetitive behaviors after 4 h of intravenous OT administration [4] and after 6 weeks of daily administrations [8, 10].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“In this view, it appears that beneficial effects of OT treatment on repetitive behaviors were mostly demonstrated in studies that adopted assessments based on self-reports (current study, [4, 8]), whereas no beneficial effects were evident in studies adopting informant-based reports of repetitive behavior [9–14].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“There is both animal (Popik et al., 1992) and human (Hollander et al., 2007(Hollander et al., , 2003) ) research to suggest systemic OT can influence social behavior and cognition”
From Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial (2016) · cites this paper as Hollander et al., 2003
In the citing paper
“oxytocin , relative to placebo, reduces repetitive stereotypic behaviors [172]”
From Social “wanting” dysfunction in autism: neurobiological underpinnings and treatment implications (2012) · cites this paper as [172]
Citations
Cites
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
The neurobiology of attachment
Insel, T. R., & Young, L. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053579 · Cited by 1,173
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
A role for central vasopressin in pair bonding in monogamous prairie voles
Winslow, J. T., Hastings, N., Carter, C. S., Harbaugh, C. R., & Insel, T. R. (1993) · Nature · doi:10.1038/365545a0 · Cited by 948 · cited 1×
“For males, vasopressin has been shown to evoke partner preference and aggression after mating (Winslow et al, 1993).”
BackgroundOxytocin is required for nursing but is not essential for parturition or reproductive behavior.
Nishimori, K., Young, L. J., Guo, Q., Wang, Z., Insel, T. R., & Matzuk, M. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11699 · Cited by 734
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728
Insel, T. R., & Hulihan, T. J. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.4.782 · Cited by 528
Oxytocin and autistic disorder: alterations in peptide forms
Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., & Morris, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01139-8 · Cited by 404
Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments
de Wied, D. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90165-x · Cited by 359
Central Nervous System Effects of the Neurohypophyseal Hormones and Related Peptides
de Wied, D., Diamant, M., & Fodor, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1009 · Cited by 327
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 704
Psychopharmacological Interventions in Autism Spectrum Disorder
Politte, L. C., Henry, C. A., & McDougle, C. J. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000030 · Cited by 75
Is crying a self-soothing behavior?
Gračanin, A., Bylsma, L. M., & Vingerhoets, A. J. J. M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00502 · Cited by 75
Beversdorf, D. Q., & MISSOURI AUTISM SUMMIT CONSORTIUM* (2016) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000351 · Cited by 74
Gobbi, G., Gaudreau, P.-O., & Leblanc, N. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000237945.35022.45 · Cited by 74
Male Anorgasmia Treated with Oxytocin
IsHak, W. W., Berman, D. S., & Peters, A. L. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00691.x · Cited by 74
Intranasal delivery of therapeutic proteins for neurological diseases
Malerba, F., Paoletti, F., Capsoni, S., & Cattaneo, A. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.588204 · Cited by 74
Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/−) reeler mice
Liu, W., Pappas, G. D., & Carter, C. S. (2005) · Neurological Research · doi:10.1179/016164105x35602 · Cited by 73
Kirsten, T. B., & Bernardi, M. M. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.013 · Cited by 73
Eaton, J. L., Holmqvist, B. I., & Glasgow, E. F. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21503 · Cited by 72
Towards a neurobiological model of offending
Mitchell, I., & Beech, A. R. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.04.001 · Cited by 72
Differentiating High-Functioning Autism and Social Phobia
Tyson, K. E., & Cruess, D. G. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1386-7 · Cited by 72
Singletary, W. M. (2015) · Neuropsychoanalysis · doi:10.1080/15294145.2015.1092334 · Cited by 73
The status of pharmacotherapy for autism spectrum disorders
Myers, S. M. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.11.1579 · Cited by 71
Altered oxytocin and vasopressin levels in autistic children in Central Saudi Arabia
AL-Ayadhi, L. Y. (2005) · Neurosciences · doi:10.17712/1658-3183.1311 · Cited by 71
Psychopharmacologic Interventions for Repetitive Behaviors in Autism Spectrum Disorders
Soorya, L. V., Kiarashi, J., & Hollander, E. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2008.06.003 · Cited by 70
Self-citationAutism Spectrum Disorders: Neurobiology and current assessment practices
Allen, R. A., Robins, D. L., & Decker, S. L. (2008) · Psychology in the Schools · doi:10.1002/pits.20341 · Cited by 70
Zak, P. J. (2010) · Journal of Economic Behavior & Organization · doi:10.1016/j.jebo.2010.09.004 · Cited by 69
Chen, F. S., & Johnson, S. C. (2011) · Social Psychological and Personality Science · doi:10.1177/1948550611410325 · Cited by 68
The altered promoter methylation of oxytocin receptor gene in autism
Yüksel, M. E., Yücetürk, B., Karataş, Ö. F., Özen, M., & Doğangün, B. (2016) · Journal of Neurogenetics · doi:10.1080/01677063.2016.1202951 · Cited by 68
Pharmacological Treatments of Pathological Gambling
Hollander, E., Sood, E., Pallanti, S., Rossi, N. B., & Baker, B. R. (2005) · Journal of Gambling Studies · doi:10.1007/s10899-004-1932-8 · Cited by 67
Self-citationTaurines, R., Schwenck, C., Lyttwin, B., Schecklmann, M., Jans, T., Reefschläger, L., Geissler, J. M., Gerlach, M., & Romanos, M. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0145-y · Cited by 66
The Roles of Oxytocin and CD38 in Social or Parental Behaviors
Lopatina, O. L., Ивановна, И. А., Salmina, A. B., & Higashida, H. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00182 · Cited by 66
Oxytocin: Parallel Processing in the Social Brain?
Dölen, G. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12284 · Cited by 65
Gillberg, C., Fernell, E., Kočovská, E., Minnis, H., Bourgeron, T., Thompson, L., & Allely, C. S. (2017) · Autism Research · doi:10.1002/aur.1777 · Cited by 65
Higashida, H., Munesue, T., Kosaka, H., Yamasue, H., Yokoyama, S., & Kikuchi, M. (2019) · Diseases · doi:10.3390/diseases7010024 · Cited by 65
Improving the precision of intranasal oxytocin research
Winterton, A., Westlye, L. T., Steen, N. E., Andreassen, O. A., & Quintana, D. S. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-00996-4 · Cited by 65
Reversal of social deficits by subchronic oxytocin in two autism mouse models
Teng, B. L., Nikolova, V. D., Riddick, N. V., Agster, K. L., Crowley, J. J., Baker, L. K., Koller, B. H., Pedersen, C. A., Jarstfer, M. B., & Moy, S. S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.025 · Cited by 65
Oxytocin and vasopressin modulate the social response to threat: a preclinical study
Bowen, M. T., & McGregor, I. S. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000388 · Cited by 63
Cd38 Gene Knockout Juvenile Mice: A Model of Oxytocin Signal Defects in Autism
Higashida, H., Yokoyama, S., Munesue, T., Kikuchi, M., Minabe, Y., & Lopatina, O. L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1369 · Cited by 63
Kumar, J. R., Rajkumar, R., Jayakody, T., Marwari, S., Hóng, J., Ma, S., Gundlach, A. L., Lai, M. K. P., & Dawe, G. S. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13564 · Cited by 63
Harony, H., & Wagner, S. (2010) · Neurosignals · doi:10.1159/000321035 · Cited by 62
Sasaki, T. G., Hashimoto, K., Oda, Y., Ishima, T., Kurata, T., Takahashi, J., Kamata, Y., Kimura, H., Niitsu, T., Komatsu, H., et al. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.029 · Cited by 62
New developments in the neurobiology of borderline personality disorder
Bohus, M., Schmahl, C. G., & Lieb, K. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0038-4 · Cited by 62
Xu, X., Shou, X., Li, J., Jia, M., Zhang, J., Guo, Y. H., Wei, Q.-Y., Zhang, X., Han, S., Zhang, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074849 · Cited by 62
Kraaijenvanger, E. J., He, Y., Spencer, H., Smith, A. K., Bos, P. A., & Boks, M. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.11.016 · Cited by 62
Zhang, R., Jia, M., Zhang, J.-S., Xu, X., Shou, X., Zhang, X., Li, L., Li, N., Han, S., & Han, J. (2012) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2012.02.001 · Cited by 61
Oxytocin and Anorexia Nervosa: A Review of the Emerging Literature
Maguire, S., O’Dell, A., Touyz, L. M., & Russell, J. D. (2013) · European Eating Disorders Review · doi:10.1002/erv.2252 · Cited by 61
Ferris, C. F., Yee, J. R., Kenkel, W. M., Dumais, K. M., Moore, K., Veenema, A. H., Kulkarni, P. P., Perkybile, A. M., & Carter, C. S. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00245 · Cited by 60
Maráz, A., Hende, B., Urbán, R., & Demetrovics, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183806 · Cited by 61
Lamy, M., & Erickson, C. A. (2018) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2018.08.015 · Cited by 60
Polygenic risk score and heritability estimates reveals a genetic relationship between ASD and OCD
Guo, W., Samuels, J. F., Wang, Y., Cao, H., Ritter, M., Nestadt, P. S., Krasnow, J., Greenberg, B. D., Fyer, A. J., McCracken, J. T., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.03.011 · Cited by 59
Goldman, M. B. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.06.004 · Cited by 59
Yamasue, H. (2012) · Brain and Development · doi:10.1016/j.braindev.2012.08.010 · Cited by 59
Vita, A., Peri, L. M. D., & Sacchetti, E. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822c1636 · Cited by 59
Teltsh, O., Kanyas, K., Rigbi, A., Greenbaum, L., Lerer, B., & Kohn, Y. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001374 · Cited by 59
Caldwell, H. K. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-1704-0_12 · Cited by 58
Yamasue, H. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12364 · Cited by 58
Locomotor activity, ultrasonic vocalization and oxytocin levels in infant CD38 knockout mice
Liu, H.-X., Lopatina, O., Higashida, C., Tsuji, T., Kato, I., Takasawa, S., Okamoto, H., Yokoyama, S., & Higashida, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.084 · Cited by 58
Iffland, M., Livingstone, N., Jorgensen, M. L., Hazell, P., & Gillies, D. M. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011769.pub2 · Cited by 58
Frantz, M., Pellissier, L. P., Pflimlin, E., Loison, S., Gandía, J., MARSOL, C., Durroux, T., Mouillac, B., Becker, J. A. J., Merrer, J. L., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00697 · Cited by 58
Autism and the amygdala: An endocrine hypothesis
Schulkin, J. A. (2007) · Brain and Cognition · doi:10.1016/j.bandc.2006.02.009 · Cited by 57
Hoge, E. A., Lawson, E. A., Metcalf, C. A., Keshaviah, A. P., Zak, P. J., Pollack, M. H., & Simon, N. M. (2012) · Depression and Anxiety · doi:10.1002/da.21973 · Cited by 57
Navazesh, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-37681-9 · Cited by 56
Yao, S., & Kendrick, K. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020323 · Cited by 55
Lee, J. H., Espinera, A. R., Chen, D., Choi, K., Caslin, A. Y., Won, S., Pecoraro, V., Xu, G., Wei, L., & Yu, S. P. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0575-x · Cited by 55
Evidence-Based Treatments for Autism Spectrum Disorder
Politte, L. C., Howe, Y. J., Nowinski, L. A., Palumbo, M., & McDougle, C. J. (2015) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-015-0031-z · Cited by 54
Bartholomeusz, C. F., Ganella, E. P., Labuschagne, I., Bousman, C., & Pantelis, C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.007 · Cited by 54
Putnam, P. T., Roman, J. M., Zimmerman, P. E., & Gothard, K. M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.05.016 · Cited by 53
Aita, C., Mizoguchi, Y., Yamamoto, M., SeguchI, Y., Yatsuga, C., Nishimura, T., Sugimoto, Y., Takahashi, D., Nishihara, R., Ueno, T., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.139 · Cited by 53
Denda, S., Takei, K., Kumamoto, J., Goto, M., Tsutsumi, M., & Denda, M. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01507.x · Cited by 53
Antiepileptic drugs for the treatment of post-traumatic stress disorder
Berlin, H. A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0035-5 · Cited by 53
Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.
Dell’Osso, B. M., Allen, A., & Hollander, E. (2005) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-1-21 · Cited by 53
Self-citationRobinson, K. J., Hazon, N., Lonergan, M., & Pomeroy, P. P. (2014) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2014.01.019 · Cited by 52
An Update on Medication Management of Behavioral Disorders in Autism
Baribeau, D. A., & Anagnostou, E. A. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0437-0 · Cited by 52
Oxytocin—a social peptide? Deconstructing the evidence
Leng, G., Leng, R., & Ludwig, M. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0055 · Cited by 51
Zebrafish orthopedia (otp) is required for isotocin cell development
Eaton, J. L., & Glasgow, E. F. (2006) · Development Genes and Evolution · doi:10.1007/s00427-006-0123-2 · Cited by 51
Lai, X., Wu, X., Hou, N., Liu, S., Li, Q., Yang, T., Miao, J., Dong, Z., Chen, J., & Li, T. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700754 · Cited by 51
Polymorphisms of candidate genes in Slovak autistic patients
Kelemenova, S., Schmidtova, E., Ficek, A., Celec, P., Kubranska, A., & Ostatnikova, D. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e32833a1eb3 · Cited by 50
Ferreira, A. C., & Osório, F. D. L. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110561 · Cited by 50
A question of balance: a proposal for new mouse models of autism
Murcia, C. L., Gulden, F. O., & Herrup, K. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.001 · Cited by 50
The Role of Neuropeptides in Suicidal Behavior: A Systematic Review
Serafini, G., Pompili, M., Lindqvist, D., Dwivedi, Y. K., & Girardi, P. (2013) · BioMed Research International · doi:10.1155/2013/687575 · Cited by 49
Research Progress in Vitamin A and Autism Spectrum Disorder
Liu, Z., Wang, J., Xu, Q., Hong, Q., Zhu, J., & Chi, X. (2021) · Behavioural Neurology · doi:10.1155/2021/5417497 · Cited by 49
Imaging-Genetics in Autism Spectrum Disorder: Advances, Translational Impact, and Future Directions
Ameis, S. H., & Szatmári, P. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00046 · Cited by 49
Pharmacologic treatment of impulsive aggression with antiepileptic drugs
Stanford, M. S., Anderson, N. E., Lake, S. L., & Baldridge, R. M. (2009) · Current Treatment Options in Neurology · doi:10.1007/s11940-009-0043-3 · Cited by 49
Suicidality and divalproex sodium: analysis of controlled studies in multiple indications
Redden, L., Pritchett, Y., Robieson, W., Kovacs, X., Garofalo, M. E., Tracy, K. A., & Saltarelli, M. (2011) · Annals of General Psychiatry · doi:10.1186/1744-859x-10-1 · Cited by 47
Grahn, P., Ottosson, J., & Uvnäs-Moberg, K. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.617814 · Cited by 46
The neurocircuitry involved in oxytocin modulation of methamphetamine addiction
Baracz, S. J., & Cornish, J. L. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.08.001 · Cited by 46
Hammock, E. A. D., & Levitt, P. R. (2006) · Human Development · doi:10.1159/000095581 · Cited by 46
Oxytocin Receptor Signaling in Vascular Function and Stroke
McKay, E. C., & Counts, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.574499 · Cited by 45
Variant in OXTR gene and functional connectivity of the hypothalamus in normal subjects
Wang, J., Qin, W., Liu, B., Wang, D., Zhang, Y., Jiang, T., & Yu, C. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.029 · Cited by 45
Targeted treatments in autism and fragile X syndrome
Gürkan, C. K., & Hagerman, R. J. (2012) · Research in Autism · doi:10.1016/j.rasd.2012.05.007 · Cited by 45
Lopatina, O. L., Liu, H.-X., Amina, S., Hashii, M., & Higashida, H. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.012 · Cited by 45
Malone, R. P., Gratz, S. S., Delaney, M. A., & Hyman, S. L. (2005) · CNS Drugs · doi:10.2165/00023210-200519110-00003 · Cited by 45
Antisocial Personality Disorder
Derefinko, K. J., & Widiger, T. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_13 · Cited by 44
Interactions of Oxytocin and Dopamine—Effects on Behavior in Health and Disease
Petersson, M., & Uvnäs‐Moberg, K. (2024) · Biomedicines · doi:10.3390/biomedicines12112440 · Cited by 44
Harden, S. W., & Frazier, C. J. (2016) · Hippocampus · doi:10.1002/hipo.22595 · Cited by 44
Audunsdottir, K., Sartorius, A. M., Kang, H., Glaser, B. D., Bøen, R., Nærland, T., Alaerts, K., Kildal, E. S.-M., Westlye, L. T., Andreassen, O. A., et al. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107067 · Cited by 43
Reser, J. E. (2011) · Evolutionary Psychology · doi:10.1177/147470491100900209 · Cited by 43
Nyffeler, J., Walitza, S., Bobrowski, E., Gundelfinger, R., & Grünblatt, E. (2014) · Journal of Molecular Psychiatry · doi:10.1186/2049-9256-2-1 · Cited by 43
Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders
Kim, K. C., Gonzales, E. L., Lázaro, M. T., Choi, C. S., Bahn, G. H., Yoo, H. J., & Shin, C. Y. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.061 · Cited by 44
Mansouri, M., Pouretemad, H., Roghani, M., Wegener, G., & Ardalan, M. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112756 · Cited by 43
Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism
Jacobson, J. D., Ellerbeck, K. A., Kelly, K., Fleming, K., Jamison, T. R., Coffey, C. W., Smith, C. M., Reese, R. M., & Sands, S. A. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.014 · Cited by 43
Emerging pharmacologic treatment options for fragile X syndrome
Erickson, C. A., Schaefer, T. L., & Davenport, M. H. (2015) · The Application of Clinical Genetics · doi:10.2147/tacg.s35673 · Cited by 44
Bertelli, M. O., Azeem, M. W., Underwood, L., Scattoni, M. L., Persico, A. M., Ricciardello, A., Sappok, T., Bergmann, T. J., Keller, R., Bianco, A., et al. (2022) · Springer eBooks · doi:10.1007/978-3-319-95720-3_16 · Cited by 43
Relationship between oxytocin receptor genotype and recognition of facial emotion.
Melchers, M., Montag, C., Markett, S. A., & Reuter, M. (2013) · Behavioral Neuroscience · doi:10.1037/a0033748 · Cited by 42
Yang, S., Dong, X., Guo, X., Han, Y., Song, H., Gao, L., Dai, W., Su, Y., & Zhang, X. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00221 · Cited by 42
Tops, S., Habel, U., & Radke, S. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.03.002 · Cited by 42
Alaerts, K., Bernaerts, S., Vanaudenaerde, B. M., Daniëls, N., & Wenderoth, N. (2019) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.01.008 · Cited by 42
Geng, Y., Zhao, W., Zhou, F., Ma, X., Yao, S., Becker, B., & Kendrick, K. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00572 · Cited by 42
Yeomans, D. C., Hanson, L. R., Carson, D. S., Tunstall, B. J., Lee, M. R., Tzabazis, A., Jacobs, D. L., & Frey, W. H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01511-7 · Cited by 42
Metadata
- Authors
- Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Hollander, Eric
- ORCID
- Hollander, Eric
- Venue
- Neuropsychopharmacology
- Published
- 2003-01
- Volume
- 28
- Issue
- 1
- Pages
- 193-198
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2036441276
- Cited by
- 689
- References
- 60
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 15 · 2018: 29 · 2017: 33 · 2016: 47 · 2015: 49 · 2014: 49 · 2013: 51 · 2012: 44
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Center for Research Resources (5 M01RR00071, M01RR000071)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- oxytocin, repetitive behavior, autism spectrum disorder, Asperger syndrome, autistic adults, oxytocin infusion, vasopressin, social behavior, self-harm, need to know, ordering behavior
- MeSH terms
- Adult, Autistic Disorder, Blood Pressure, Body Temperature, Double-Blind Method, Female, Humans, Infusions, Intravenous, Male, Oxytocin, Psychiatric Status Rating Scales, Pulse, Treatment Outcome, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
